{"topic_id":"ade_cefovecin_adverse_events","category":"ade","context":"---\ntopic_id: ade_cefovecin_adverse_events\ncategory: ade\ntitle: \"FDA ADE reports for Cefovecin (third-generation cephalosporin antibiotic (injectable, dogs & cats)) — total reports, species & reaction breakdown\"\nlang: en\nsource: \"openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-22\"\nsource_file: pdf-raw/ade/ade_active_ingredients_2026-07-22_b8.json\ndate_parsed: 2026-07-22\ntokens_estimated: 204\nverification:\n  method: substring_match\n  claims: 34\n  passed: 34\n  date: 2026-07-22\n---\n\n# Cefovecin — FDA Animal & Veterinary Adverse Event (ADE) Reports\n\nSource: openFDA `animalandveterinary/event.json`, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Cefovecin is a third-generation cephalosporin antibiotic (injectable, dogs & cats).\n\n## Total reports\nCefovecin: 9343\n\n## Reports by species (top entries)\n- Cat 5650\n- Dog 2820\n- Human 29\n- Guinea Pig 3\n- Ferret 2\n- Other 2\n\n## Top reported reactions (VEDDRA terms, top entries)\n- Lethargy (see also Central nervous system depression in 'Neurological') 1755\n- Vomiting 1319\n- Anorexia 1213\n- Death 1054\n- Death by euthanasia 754\n- Diarrhoea 687\n- Weight loss 659\n- Fever 600\n- Lack of efficacy - NOS 592\n- Other abnormal test result NOS 588\n\n\"Lack of efficacy\" terms denote product-performance reports, not adverse reactions.\n\nSource JSON: `pdf-raw/ade/ade_active_ingredients_2026-07-22_b8.json` (openFDA animalandveterinary/event.json, pulled 2026-07-22).\n","sources":[],"tokens_estimated":282,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}